Targeted gene modification by parvoviral vectors
CA 2289277 C · Owner: University Of Washington · Inventors: Hirata, Roli K.; Russell, David W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides methods for obtaining targeted gene modification in vertebrate cells using parvoviruses, including adeno-associated virus (AAV). The parvoviral vectors used in the claimed methods are capable of targeting a specific genetic modification to a preselected target locus in a cellular genome by homologous pairing.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 20, 1998 and granted February 12, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 20, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 20, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.